Wordt geladen...
What’s Next After Anamorelin?
PURPOSE: In spite of its relevance, treatments for the cancer anorexia and cachexia syndrome (CACS) are not available. One of the agents that recently reached phase III clinical trials is anamorelin. Its development, along with that of other agents for this indication will be reviewed here, with a f...
Bewaard in:
| Gepubliceerd in: | Curr Opin Support Palliat Care |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5776683/ https://ncbi.nlm.nih.gov/pubmed/28957883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SPC.0000000000000299 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|